• In the media
  • GSK leads drugmakers’ fight against superbugs
Media - published on 23 Jan 2018

GSK leads drugmakers’ fight against superbugs

Clive Cookson, Science Editor of The Financial Times, reports on the companies who are most active in curbing AMR. Cookson covers the Antimicrobial Resistance Benchmark, focusing on the key findings on the performance of large research-based pharmaceutical companies, generic medicine manufacturers and biopharmaceutical companies in the scope of analysis.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.